Company Description
ROKIT America is committed to extending human healthspan and enhancing quality of life in an aging society through its proprietary Reverse Aging Product which is intended to support cellular health and aging-related biological processes at the molecular level, and its artificial intelligence hyper-personalized Organ Regeneration Platform, a proprietary technology developed by our parent company, ROKIT Healthcare, which is intended to provide regenerative medicine solutions in the Americas.
Since its founding in 2019, the Company has focused on the research and development of dietary supplements centered around β-Nicotinamide Mononucleotide (“NMN”).
We have launched a range of NMN-based products into global markets, including the United States. Our flagship product line, ROKIT AMERICA NMN, combines NMN with pterostilbene, a naturally occurring antioxidant.
| Country | United States |
| Founded | 2019 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| CEO | Seok Hwan You |
Contact Details
Address: 3435 Wilshire Blvd, Suite 2925 Los Angeles, CA 90010 United States | |
| Phone | (678) 861-0046 |
| Website | rokitamerica.co.kr |
Stock Details
| Ticker Symbol | RKAM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 2087716 |
| Employer ID | 38-4124442 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Seok Hwan You | Chief Executive Officer and Chairman of the Board of Directors |
| Ha Young Kim | Chief Financial Officer and Director |
| Seong Mo Jee | Chief Strategy Officer |
| Min Gu Lee | Chief Medical Officer |
| Won Kyung Choi | Chief Technology Officer |
| Woo Young Kim | Chief Operation Officer |
| Min Kyoung Choi | Chief Legal Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 15, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Apr 2, 2026 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Mar 11, 2026 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jan 16, 2026 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Oct 2, 2025 | DRS | [Cover] Draft Registration Statement |